Becton Dickinson (BDX) Liabilities and Shareholders Equity (2009 - 2026)
Becton Dickinson (BDX) reported Liabilities and Shareholders Equity of $50.8 billion for Q1 2026, down 6.67% year-over-year from $54.5 billion in Q1 2025, and down 7.31% quarter-over-quarter from $54.8 billion in Q4 2025.
Becton Dickinson (BDX) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $50.8 billion in Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $50.8 billion, down 6.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $215.9 billion (down 2.75% YoY), and the FY2025 annual result was $55.3 billion, down 3.42% from the prior year.
- Liabilities and Shareholders Equity slipped to $50.8 billion in Q1 2026 per BDX's latest filing, from $54.8 billion in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $57.3 billion in Q3 2024 and troughed at $50.8 billion in Q1 2026.
- A 5-year average of $54.0 billion and a median of $54.4 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2024 and 2026: Liabilities and Shareholders Equity grew 8.54% in 2024, then declined 6.67% in 2026.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $53.1 billion in 2022, then declined by 1.61% to $52.3 billion in 2023, then advanced by 4.57% to $54.7 billion in 2024, then increased by 0.32% to $54.8 billion in 2025, then retreated by 7.31% to $50.8 billion in 2026.
- Business Quant data shows BDX's Liabilities and Shareholders Equity at $50.8 billion in Q1 2026, $54.8 billion in Q4 2025, and $55.3 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 39.01 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 8.78 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.11 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 14.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 6.31 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 19.85 Bn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 5.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.83 Bn |
| Dec 31, 2025 | 54.84 Bn |
| Sep 30, 2025 | 55.33 Bn |
| Jun 30, 2025 | 54.90 Bn |
| Mar 31, 2025 | 54.47 Bn |
| Dec 31, 2024 | 54.67 Bn |
| Sep 30, 2024 | 57.29 Bn |
| Jun 30, 2024 | 55.58 Bn |
| Mar 31, 2024 | 54.16 Bn |
| Dec 31, 2023 | 52.27 Bn |
| Sep 30, 2023 | 52.78 Bn |
| Jun 30, 2023 | 53.02 Bn |
| Mar 31, 2023 | 54.39 Bn |
| Dec 31, 2022 | 53.13 Bn |
| Sep 30, 2022 | 52.93 Bn |
| Jun 30, 2022 | 53.20 Bn |
| Mar 31, 2022 | 54.79 Bn |
| Dec 31, 2021 | 53.36 Bn |
| Sep 30, 2021 | 53.87 Bn |
| Jun 30, 2021 | 54.33 Bn |